<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1137178E-ABE5-4532-862A-1EE958558659"><gtr:id>1137178E-ABE5-4532-862A-1EE958558659</gtr:id><gtr:firstName>Francisco</gtr:firstName><gtr:surname>Iborra</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137973816"><gtr:id>EE7EB280-E5FA-4DDE-B966-6F76CF3D474D</gtr:id><gtr:title>Nuclear organisation and gene expression in Haematopoiesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137973816</gtr:grantReference><gtr:abstractText>We would like to understand the fundamental question of the control of cell differentiation; how one cell move from one genetic program to another. The difference between the cells of our body is the set of genes they express. Pathological situations tend to be associated with aberrant patterns of gene expression. Gene expression starts at the DNA, which can be modified to be silent. The second control level is the kind of modifications on the proteins wrapping the DNA, again making the gene either silent or active. Thirdly, it is essential to have the right protein factors directing the transcription machinery to where to start transcribing the gene. These proteins work in teams and the relative abundance of each protein will drive the cell to take one path or another. For these reasons our group plan to do a detailed analysis of all these different factors at the single cell level, to try to understand the regulation of cell differentiation and pathology.</gtr:abstractText><gtr:technicalSummary>The aim of our group is to understand how gene expression is integrated in the nuclear context. The transcription process involves cis and trans components and the right combination of both is required for transcription to proceed. Transcription by RNA polymerase II involves the assembly of general and specific transcription factors on the core promoter to form a preinitiation complex. Specific transcription factors are responsible for specific patterns of gene expression, acting on specific promoters. Understanding how these factors interact with their partners and targets is fundamental to understanding cell type specification. There is increasing evidence that this process is controlled by networks of interacting transcription factors and that subtle variations in protein partners may have profound consequences for gene expression programs.On the other hand, epigenetic modifications regulate the interpretation of genetic information. Epigenetic gene regulation works at two levels. One level is DNA methylation, the other chromatin modification. DNA methylation is found at the C-5 position of cytosine residues. DNA methylation is associated with gene silencing by inhibition of interaction between transcription factors and DNA, and recruitment of heterochromatin proteins. Chromatin is another central target for epigenetic modifications. Transcriptionally inactive heterochromatin is packed densely, whereas active euchromatin is less condensed. The core components of chromatin are the histone octamers, which consist of the histones H2A, H2B, H3 and H4. The histones can be subject to covalent modifications. These modifications can be acetylation, phosphorylation or methylation. Histone acetylation has been found to correlate with active transcription, likewise histone phosphorylation. However, histone methylation appears to have diverse functions in the control of gene activity.Both processes, transcription factor binding to the promoter and chromatin modification are interlinked. Therefore we cannot understand one without the other.Our group is focused on the study of Haematopoiesis. We plan a comprehensive analysis of transcription factors and chromatin status in relation to gene expression. We plan to do a single cell analysis of the different factors affecting cell lineage commitment. Once we have accomplished the analysis we will test how changing the balance between the different factors emerging from the analysis can drive the cell into cell specification and pathology.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-07-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>968804</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>41EF25F3-E21B-4D6B-BB80-0F83DF52927A</gtr:id><gtr:title>NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fff9ad9ad870a670fe88aee2fe4bc105"><gtr:id>fff9ad9ad870a670fe88aee2fe4bc105</gtr:id><gtr:otherNames>Gupta R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>9A769B5F4D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD1549EA-81A4-4269-91EF-7C12ABB3B93E</gtr:id><gtr:title>Association between active genes occurs at nuclear speckles and is modulated by chromatin environment.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5972aac6e4f4128eb96dcaf53080fb8"><gtr:id>b5972aac6e4f4128eb96dcaf53080fb8</gtr:id><gtr:otherNames>Brown JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>82118F49CEA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7054E7B2-FD75-47C2-B293-F69E1F9A32B4</gtr:id><gtr:title>How transcriptional and epigenetic programmes are played out on an individual mammalian gene cluster during lineage commitment and differentiation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0067-8694</gtr:issn><gtr:outcomeId>21168CCFF74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB12393B-ACDB-4620-9053-34A97D88C3DE</gtr:id><gtr:title>Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa5e23ae3b15b0a7aff6b72b42090ed2"><gtr:id>aa5e23ae3b15b0a7aff6b72b42090ed2</gtr:id><gtr:otherNames>Enver T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>CCA87B46FDE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0DC5BA1-B9CC-4C3D-9C82-857B78B40BD0</gtr:id><gtr:title>Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/411cfef950b092ecfe58cb398e42b965"><gtr:id>411cfef950b092ecfe58cb398e42b965</gtr:id><gtr:otherNames>Hamlett I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>9B2B7870579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33B957B9-55CD-4784-9C85-8376D587D9EA</gtr:id><gtr:title>Wide confocal cytometry: a new approach to study proteomic and structural changes in the cell nucleus during the cell cycle.</gtr:title><gtr:parentPublicationTitle>Histochemistry and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2acf03a6f2eb0a6a90d8223e486db038"><gtr:id>2acf03a6f2eb0a6a90d8223e486db038</gtr:id><gtr:otherNames>Iborra FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0948-6143</gtr:issn><gtr:outcomeId>CE9BDF81217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DFBB17A-A19A-4889-8EB1-031AC136EE3B</gtr:id><gtr:title>Coregulated human globin genes are frequently in spatial proximity when active.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5972aac6e4f4128eb96dcaf53080fb8"><gtr:id>b5972aac6e4f4128eb96dcaf53080fb8</gtr:id><gtr:otherNames>Brown JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>B82C972317F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1DACB82-F86C-43B7-A05B-C318AB8936E0</gtr:id><gtr:title>ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfb73211fc328f0a332a9010d639053f"><gtr:id>cfb73211fc328f0a332a9010d639053f</gtr:id><gtr:otherNames>Schuh AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>E7C061DF1F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>117FE44A-50FE-44BE-8846-094033FE5A22</gtr:id><gtr:title>GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4348336642c08712574f29caa182be3"><gtr:id>e4348336642c08712574f29caa182be3</gtr:id><gtr:otherNames>Kuhl C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>D2142AFA56B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA6E1EBA-51DE-42A9-8EEA-BB7C219D8312</gtr:id><gtr:title>[Study of apoptosis and mitosis mechanisms in the eye. Experimental model of gestational toxic syndrome].</gtr:title><gtr:parentPublicationTitle>Archivos de la Sociedad Espanola de Oftalmologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/367a6348fb6792bc219354a4be35daac"><gtr:id>367a6348fb6792bc219354a4be35daac</gtr:id><gtr:otherNames>Pons-V?zquez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0365-6691</gtr:issn><gtr:outcomeId>6430CBF62AF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF029B58-24FE-4561-AB86-9F56E2B00090</gtr:id><gtr:title>Can visco-elastic phase separation, macromolecular crowding and colloidal physics explain nuclear organisation?</gtr:title><gtr:parentPublicationTitle>Theoretical biology &amp; medical modelling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2acf03a6f2eb0a6a90d8223e486db038"><gtr:id>2acf03a6f2eb0a6a90d8223e486db038</gtr:id><gtr:otherNames>Iborra FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1742-4682</gtr:issn><gtr:outcomeId>88C7398E4AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26A920F4-BDB2-48E1-9156-F1D7A44DC7F0</gtr:id><gtr:title>Postnatal thyroid hormone supplementation rescues developmental abnormalities induced by congenital-neonatal hypothyroidism in the rat retina.</gtr:title><gtr:parentPublicationTitle>Ophthalmic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1708b6b1528c56acbc3a4f1ab324cbfa"><gtr:id>1708b6b1528c56acbc3a4f1ab324cbfa</gtr:id><gtr:otherNames>Pinazo-Dur?n MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0030-3747</gtr:issn><gtr:outcomeId>798942FCE62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD6CCDFC-1891-4486-A3EB-8569BB62CAB5</gtr:id><gtr:title>Specific detection of RNA on ultra-thin sections.</gtr:title><gtr:parentPublicationTitle>Journal of structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/165b34140844407e42850713b2988fac"><gtr:id>165b34140844407e42850713b2988fac</gtr:id><gtr:otherNames>Calabuig J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1047-8477</gtr:issn><gtr:outcomeId>E3C7413B6BA</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137973816</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>